Head to Head Comparison: Puxin (NYSE:NEW) and Four Seasons Edu (Cayman) (NYSE:FEDU)

Share on StockTwits

Puxin (NYSE:NEW) and Four Seasons Edu (Cayman) (NYSE:FEDU) are both small-cap consumer discretionary companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.

Profitability

This table compares Puxin and Four Seasons Edu (Cayman)’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Puxin -31.06% -89.64% -18.49%
Four Seasons Edu (Cayman) -0.15% -0.07% -0.05%

Analyst Ratings

This is a summary of recent ratings and target prices for Puxin and Four Seasons Edu (Cayman), as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Puxin 0 1 1 0 2.50
Four Seasons Edu (Cayman) 1 0 0 0 1.00

Puxin currently has a consensus price target of $28.43, suggesting a potential upside of 405.87%. Four Seasons Edu (Cayman) has a consensus price target of $4.00, suggesting a potential upside of 122.22%. Given Puxin’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Puxin is more favorable than Four Seasons Edu (Cayman).

Institutional and Insider Ownership

7.8% of Puxin shares are held by institutional investors. Comparatively, 50.4% of Four Seasons Edu (Cayman) shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Puxin and Four Seasons Edu (Cayman)’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Puxin $324.07 million 1.43 -$121.21 million N/A N/A
Four Seasons Edu (Cayman) $50.16 million 0.43 -$90,000.00 N/A N/A

Four Seasons Edu (Cayman) has lower revenue, but higher earnings than Puxin.

About Puxin

Puxin Limited, through its subsidiaries, provides after-school education services in China. It offers a range of K-12 and study-abroad tutoring programs designed to help students prepare for admission tests and applications for top schools, universities, and graduate programs in China and other countries. The company also provides group class courses; personalized tutoring courses; English tutoring services for children in kindergarten; and extra-curricular courses to students, such as painting, calligraphy, music, debate, and science, as well as offers Web-based and mobile-based platforms for K-12 tutoring services. In addition, it sells education materials; and provides advertisement, study consulting, and training services. As of March 31, 2018, the company had a network of 397 learning centers; and 4 schools providing extra-curricular education courses. Puxin Limited was founded in 2014 and is headquartered in Beijing, China.

About Four Seasons Edu (Cayman)

Four Seasons Education (Cayman) Inc., together with its subsidiaries, provides after-school education services in the People's Republic of China. The company's education services comprise standard programs; personalized Ivy programs; and special programs, including competition workshops and courses delivered to K-12 schools. It also offers education and management consulting services. The company offers after-school education services for kindergarten, elementary, and middle school students. As of February 28, 2018, the company operated 31 learning centers in Shanghai and 7 in other cities. Four Seasons Education (Cayman) Inc. was founded in 2007 and is based in Shanghai, the People's Republic of China.

Receive News & Ratings for Puxin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Puxin and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Bradesco Corretora Reiterates “Neutral” Rating for Ternium
Bradesco Corretora Reiterates “Neutral” Rating for Ternium
Meridian Bioscience  Rating Lowered to Sell at ValuEngine
Meridian Bioscience Rating Lowered to Sell at ValuEngine
Unum Therapeutics  Price Target Lowered to $13.00 at Wedbush
Unum Therapeutics Price Target Lowered to $13.00 at Wedbush
Zendesk  Research Coverage Started at Compass Point
Zendesk Research Coverage Started at Compass Point
Afya  Coverage Initiated at Bank of America
Afya Coverage Initiated at Bank of America
Telefonica  Downgraded to “Neutral” at Bank of America
Telefonica Downgraded to “Neutral” at Bank of America


 
© 2006-2019 Zolmax.